Integrated Diagnostics Holdings (IDHC): Offer for the company

This situation live

£213m · 36.6p · −14% since the first step

Takeover target

Offer for the company

offer

Bidderprivate equity

Every step · 2

23 Jun 2026 offer – Following this purchase, Hena holds 288,445,383 Ordinary Shares, representing approximately 49.62 per cent. of the Company's existing issued ordinary share... ↗
13 Aug 2026 offer – Bidco counted, together with the 288,445,383 IDH Shares held by Bidco following completion of the Elliott Transaction, 329,447,709 IDH Shares, representing... ↗

What is happening

Integrated Diagnostics Holdings: Offer for the company – offer. ['offer']

In short: Hena, owned by CEO Dr Hend El-Sherbini and her mother, made a Rule 9 mandatory final cash offer at USD0.50 on 23 June 2026 after buying Elliott's 21.67%. The offer was declared unconditional on 29 July 2026 and closed on 12 August 2026. Hena ended with 56.67%, below the 75% needed for delisting, leaving a 43.33% free float.
Announced: 23 Jun 2026 · offer
Latest: 13 Aug 2026 · approach
Delisting: Needed 75%; Hena is below that threshold, and no delisting is mentioned
Relationship agreement: None entered into or intended by Bidco
Offer: US$0.50 cash per IDH Share, mandatory final offer announced 23 June 2026
Acceptances: 40,631,301 IDH Shares, about 6.98%, valid at 3.00 p.m. on 28 July 2026
Bidco holding: 329,076,684 shares counted, about 56.60% of issued share capital
Status: Acceptance Condition was the sole condition; Offer declared unconditional on 29 July 2026
Final holding: Hena 56.67% after the offer closed on 12 August 2026
Free float: 43.33% held by public shareholders

Briefing Pro

What it does, how it got here, what management promised and delivered – written from its own announcements.

From the company's own announcements. Not investment advice.

Also at Integrated Diagnostics Holdings 0 open